/

Society

Ga

Not verified

Galapagos NV

What we write about

BiotechnologyForeign Policy

34 Press releases

View all press releases

18/12/2025

Biotechnology

Foreign Policy

Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus

Source

Issuer

1.00

0

07/12/2025

Biotechnology

Foreign Policy

Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025

Source

Issuer

1.00

0

25/11/2025

Biotechnology

Foreign Policy

Galapagos Receives Transparency Notifications from Bank of America

Source

Issuer

1.00

0

05/11/2025

Biotechnology

Foreign Policy

Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update

Source

Issuer

1.00

0

03/11/2025

Biotechnology

Foreign Policy

Galapagos to Present New Data from Cell Therapy Program at ASH 2025

Source

Issuer

1.00

0

30/10/2025

Biotechnology

Foreign Policy

Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development

Source

Issuer

1.00

0

23/10/2025

Biotechnology

Foreign Policy

Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors

Source

Issuer

1.00

0

20/10/2025

Biotechnology

Foreign Policy

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

Source

Issuer

1.00

0

16/10/2025

Biotechnology

Foreign Policy

Galapagos Announces Appointment of Fred Blakeslee as General Counsel

Source

Issuer

1.00

0

01/10/2025

Biotechnology

Foreign Policy

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business

Source

Issuer

1.00

0

Followers

0

Compatibility

0